A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
Medicaid is doing a novel payment system for the new, promising and expensive sickle cell treatment. It may become a model ...
Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...
The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...
Morning Overview on MSN
Gene hacking is coming and it could rewrite what it means to be human
For the first time, the tools to rewrite human biology are moving from speculative fiction into regulated clinics and ...
A Catholic priest has publicly shared two genotype combinations that he would never wed as a priest. In a lenghty post, he ...
Dayo Adu, the inaugural chairman of the Healthcare & Pharmaceuticals Law Committee of the Nigerian Bar Association Section ...
Healthbeat on MSN
Blood supply shortage, Legionnaires’ disease in Harlem, a cold snap, and respiratory viruses
This is a packed week for New York health news. From an urgent call for blood donations and Legionnaires’ disease cases in Harlem, to a Code Blue warning for freezing temperatures and the ongoing ...
NASHVILLE, Tenn. – Sickle cell disease is a devastating, inherited blood disorder that affects an estimated eight million people worldwide and roughly 100,000 here in the United States, most of them ...
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results